• About
  • Partnerships
  • Challenges
  • Awards
  • Grant Opportunities
  • News

Creating a Cross-Serotype Poliovirus VLP Vaccine

Peter Nara of Biological Mimetics, Inc. in the U.S. will use a new vaccine technology to produce non-infectious poliovirus-like particles that can be used in one highly effective, low-cost polio vaccine capable of inducing protective immunity against all circulating serotypes.

More information about The Poliovirus Endgame: Create Innovative Ways to Accelerate, Sustain, and Monitor Eradication (Round 7)

Great ideas come from everywhere.

Sign up for email updates of the latest grant opportunities and awards.

View the Grand Challenges partnership network

The Bill & Melinda Gates Foundation is part of the Grand Challenges partnership network. Visit www.grandchallenges.org to view the map of awarded grants across this network and grant opportunities from partners.